BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

86 related articles for article (PubMed ID: 3040472)

  • 1. Methylation of the enhancer region of avian sarcoma virus long terminal repeat suppresses transcription.
    Guntaka RV; Gowda S; Wagner H; Simon D
    FEBS Lett; 1987 Sep; 221(2):332-6. PubMed ID: 3040472
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Identification of sequences in the long terminal repeat of avian sarcoma virus required for efficient transcription.
    Gowda S; Rao AS; Kim YW; Guntaka RV
    Virology; 1988 Jan; 162(1):243-7. PubMed ID: 2827383
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Functional analysis of the transcription control region located within the avian retroviral long terminal repeat.
    Cullen BR; Raymond K; Ju G
    Mol Cell Biol; 1985 Mar; 5(3):438-47. PubMed ID: 2985953
    [TBL] [Abstract][Full Text] [Related]  

  • 4. CArG, CCAAT, and CCAAT-like protein binding sites in avian retrovirus long terminal repeat enhancers.
    Zachow KR; Conklin KF
    J Virol; 1992 Apr; 66(4):1959-70. PubMed ID: 1312613
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Identification of three sequence-specific DNA-binding proteins which interact with the Rous sarcoma virus enhancer and upstream promoter elements.
    Goodwin GH
    J Virol; 1988 Jun; 62(6):2186-90. PubMed ID: 2835519
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Functional and defective components of avian endogenous virus long terminal repeat enhancer sequences.
    Habel DE; Dohrer KL; Conklin KF
    J Virol; 1993 Mar; 67(3):1545-54. PubMed ID: 8382309
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Transcriptional activity of avian retroviral long terminal repeats directly correlates with enhancer activity.
    Cullen BR; Raymond K; Ju G
    J Virol; 1985 Feb; 53(2):515-21. PubMed ID: 2982034
    [TBL] [Abstract][Full Text] [Related]  

  • 8. An upstream regulatory domain of avian tumor virus long terminal repeat is required for the expression of a procaryotic neomycin gene in eucaryotic cells.
    Mitsialis SA; Caplan S; Guntaka RV
    Mol Cell Biol; 1983 Nov; 3(11):1975-84. PubMed ID: 6318077
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Effect of specific nucleotide sequences on the transcription activity of long terminal repeats of avian retroviruses].
    Kraevskiĭ VA; Panin VM; Veretennikov NA
    Genetika; 1996 Mar; 32(3):341-7. PubMed ID: 8723626
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Identification of a third protein factor which binds to the Rous sarcoma virus LTR enhancer: possible homology with the serum response factor.
    Boulden A; Sealy L
    Virology; 1990 Jan; 174(1):204-16. PubMed ID: 2152992
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Alternating purine-pyrimidine tract activates transcription from the Rouse sarcoma virus LTR lacking promoter and enhancer elements.
    Krajewski WA
    FEBS Lett; 1995 Jan; 358(1):13-6. PubMed ID: 7821420
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The GT-rich sequence in the U5 region of Rous sarcoma virus long terminal repeat is required for transcription termination and 3' processing.
    Cleavinger PJ; Kandala JC; Guntaka RV
    Folia Biol (Praha); 1997; 43(4):153-60. PubMed ID: 9338122
    [TBL] [Abstract][Full Text] [Related]  

  • 13. At least two nuclear proteins bind specifically to the Rous sarcoma virus long terminal repeat enhancer.
    Sealey L; Chalkley R
    Mol Cell Biol; 1987 Feb; 7(2):787-98. PubMed ID: 3029568
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Identification of EFIV, a stable factor present in many avian cell types that transactivates sequences in the 5' portion of the Rous sarcoma virus long terminal repeat enhancer.
    Houtz EK; Conklin KF
    J Virol; 1996 Jan; 70(1):393-401. PubMed ID: 8523553
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Activation of an endogenous retrovirus enhancer by insertion into a heterologous context.
    Conklin KF
    J Virol; 1991 May; 65(5):2525-32. PubMed ID: 1850026
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Growth hormone gene expression in eukaryotic cells directed by the Rous sarcoma virus long terminal repeat or cytomegalovirus immediate-early promoter.
    Pasleau F; Tocci MJ; Leung F; Kopchick JJ
    Gene; 1985; 38(1-3):227-32. PubMed ID: 2998944
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Cloning of Rous sarcoma virus enhancer factor genes. II. RSV-EF-II, abundantly expressed in fibroblasts and muscle tissue, binds to an octamer sequence, 5'-GTACCACC-3', in the noncoding strand of RSV enhancer.
    Cleavinger PJ; Shin BA; Kandala JC; Nambiar A; Swamynathan SK; Guntaka RV
    Virology; 1996 Aug; 222(1):133-43. PubMed ID: 8806494
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Inhibition of the rous sarcoma virus long terminal repeat-driven transcription by in vitro methylation: different sensitivity in permissive chicken cells versus mammalian cells.
    Hejnar J; Plachý J; Geryk J; Machon O; Trejbalová K; Guntaka RV; Svoboda J
    Virology; 1999 Mar; 255(1):171-81. PubMed ID: 10049832
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Location of cis-acting regulatory sequences in the human T-cell leukemia virus type I long terminal repeat.
    Rosen CA; Sodroski JG; Haseltine WA
    Proc Natl Acad Sci U S A; 1985 Oct; 82(19):6502-6. PubMed ID: 2995968
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Two elements in the bovine leukemia virus long terminal repeat that regulate gene expression.
    Derse D; Casey JW
    Science; 1986 Mar; 231(4744):1437-40. PubMed ID: 3006241
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.